LNTH
HEALTHCARELantheus Holdings Inc
$86.15+0.33 (+0.38%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving LNTH Today?
No stock-specific AI insight has been generated for LNTH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$47.25$93.00
$86.15
Fundamentals
Market Cap$5.6B
P/E Ratio25.3
EPS$3.41
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding65.1M
LNTH News
22 articles- Lantheus (LNTH) Q1 2026 Earnings TranscriptMotley Fool·May 8, 2026
- These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 ResultsBenzinga·May 8, 2026
- LNTH: Lantheus Reports 1Q:26 Financial and Operational ResultsYahoo Finance·May 8, 2026
- Lantheus Holdings (LNTH) Valuation Check After Q1 Earnings Beat And FDA Approval CatalystsYahoo Finance·May 8, 2026
- Lantheus Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Lantheus Holdings (LNTH) One Off Gain Lifts Margins And Tests Earnings Quality NarrativesSimply Wall Street·May 8, 2026
- Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 SalesYahoo Finance·May 7, 2026
- Lantheus Reports First Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 7, 2026
- Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern TimeYahoo Finance·Apr 23, 2026
- 1 Healthcare Stock to Target This Week and 2 We IgnoreYahoo Finance·Apr 22, 2026
- Here is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest InYahoo Finance·Apr 19, 2026
- A Look At Lantheus Holdings (LNTH) Valuation As Cautious Sentiment Follows Expected Sales And Margin PressureYahoo Finance·Apr 10, 2026
- 3 Profitable Stocks We Think Twice AboutYahoo Finance·Apr 9, 2026
- 3 Cash-Producing Stocks Walking a Fine LineYahoo Finance·Apr 8, 2026
- 1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We IgnoreYahoo Finance·Apr 7, 2026
- Jefferies Lifts PT on Lantheus Holdings (LNTH) to $110 From $105 – Here’s WhyYahoo Finance·Mar 31, 2026
- 3 Russell 2000 Stocks We’re Skeptical OfYahoo Finance·Mar 25, 2026
- Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)Yahoo Finance·Mar 17, 2026
- Why Lantheus (LNTH) Is Up 5.4% After Dual FDA Wins In Radiopharmaceutical Oncology ExpansionYahoo Finance·Mar 13, 2026
- 3 Reasons to Sell LNTH and 1 Stock to Buy InsteadYahoo Finance·Mar 12, 2026
- Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics StocksYahoo Finance·Mar 11, 2026
- Why Lantheus Holdings Stock Popped by Almost 12% Last MonthMotley Fool·Mar 9, 2026
All 22 articles loaded
Price Data
Open$86.15
Previous Close$85.82
Day High$87.59
Day Low$85.26
52 Week High$93.00
52 Week Low$47.25
52-Week Range
$47.25$93.00
$86.15
Fundamentals
Market Cap$5.6B
P/E Ratio25.3
EPS$3.41
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.2%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding65.1M
About Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—